Steven Reinberg March 26, 2014 A new drug may help lung cancer patients when they become resistant to the first-line medication crizotinib, researchers find. Alice Shaw, associate professor of medicine at Massachusetts General Hospital, is the lead researcher. Read full article
Researchers Discover Bias in AI Models That Analyze Pathology Samples December 16, 2025 The team created a new tool that reduces bias and improves cancer diagnosis across populations
New Artificial Intelligence Model Could Speed Rare Disease Diagnosis November 24, 2025 PopEVE can identify genetic variants most likely to cause severe disease, death
Gordon Freeman, Arlene Sharpe Receive Inaugural Gretener-Thürlemann Prize December 4, 2025 $625,000 prize recognizes breakthrough research into cancer immunotherapy
